CREDIT AGREEMENT dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, THE LENDERS FROM TIME TO TIME PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY...Credit Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 28th, 2008 Company Industry JurisdictionCredit Agreement (“Agreement”) dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY SENIOR FUNDING, INC. as Co-Syndication Agents, and DnB NOR BANK ASA and THE BANK OF NOVA SCOTIA, as Co-Documentation Agents.
AMENDMENT TO CHANGE IN CONTROL AGREEMENTChange in Control Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances)
Contract Type FiledNovember 28th, 2008 Company IndustryTHIS AMENDMENT to the CHANGE-IN-CONTROL AGREEMENT (the “Amendment”) is made and entered into as of November 21, 2008, by and between INVITROGEN CORPORATION, a Delaware corporation (the “Company”) and David F. Hoffmeister (“Executive”).
LIMITED WAIVER AND RELEASE OF RIGHTS TO TERMINATE FOR GOOD REASON UNDER THE CHANGE-IN-CONTROL AGREEMENTLife Technologies Corp • November 28th, 2008 • Biological products, (no disgnostic substances) • California
Company FiledNovember 28th, 2008 Industry JurisdictionThis Limited Waiver and Release of Rights to Terminate for Good Reason Under the Change-in-Control Agreement (“Waiver and Release of Rights Agreement”) by and between INVITROGEN CORPORATION, a Delaware corporation (“Company”), and Pete M. Leddy (“Executive”), dated as of the 21st day of November 2008.
SECURITY AGREEMENT dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, THE GUARANTORS FROM TIME TO TIME PARTY HERETO and BANK OF AMERICA, N.A., as Collateral AgentSecurity Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 28th, 2008 Company Industry JurisdictionSECURITY AGREEMENT dated as of November 21, 2008 (as amended, modified or supplemented from time to time, this “Agreement”) among LIFE TECHNOLOGIES CORPORATION, the GUARANTORS from time to time parties hereto and BANK OF AMERICA, N.A., as Collateral Agent for the benefit of the Secured Parties referred to herein.
PLEDGE AGREEMENT dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, THE GUARANTORS FROM TIME TO TIME PARTY HERETO and BANK OF AMERICA, N.A., as Collateral AgentPledge Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 28th, 2008 Company Industry JurisdictionPLEDGE AGREEMENT dated as of November 21, 2008 (as amended, modified or supplemented from time to time, this “Agreement”) among the LOAN PARTIES from time to time party hereto and BANK OF AMERICA, N.A., as Collateral Agent for the benefit of the Secured Parties referred to herein.
November 20, 2008 Mark P. Stevenson 225 Willowbrook Drive Portola Valley, CA 94028 Dear Mark: As you know, Invitrogen Corporation (the “Company”) has entered into an Agreement and Plan of Merger among Atom Acquisition, LLC (“Merger Sub”) and Applera...Employment Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledNovember 28th, 2008 Company Industry Jurisdiction
LIMITED WAIVER AND RELEASE OF RIGHTS TO TERMINATE FOR GOOD REASON UNDER THE CHANGE-IN-CONTROL AGREEMENTLife Technologies Corp • November 28th, 2008 • Biological products, (no disgnostic substances) • California
Company FiledNovember 28th, 2008 Industry JurisdictionThis Limited Waiver and Release of Rights to Terminate for Good Reason Under the Change-in-Control Agreement (“Waiver and Release of Rights Agreement”) by and between INVITROGEN CORPORATION, a Delaware corporation (“Company”), and Nicolas Barthelemy (“Executive”), dated as of the 21st day of November 2008.